Let us know what's on your mind
Effecting over 18 Million and ranging from fractures to debilitating bone diseases, bone health has far reaching consequences impacting an individual’s ability to perform the most essential functions of day to day life
Effecting over 18 Million and ranging from fractures to debilitating bone diseases, bone health has far reaching consequences impacting an individual’s ability to perform the most essential functions of day to day life
LEARN MOREOur platform is aimed and lowering the negative impact on the 22M and 500K patients who experience fractures and Spinal fusion incidents annually in the US.
LEARN MOREOsteogenesis Imperfecta is the first of four rare bone diseases we are targeting in our early development pipeline.
LEARN MOREA phase 1 SAD study will address Safety, Tolerability and PK questions that will lead to P1b MAD study where we will expand our inquiry into issues surrounding dosing and efficacy in subjects with bone fractures.